✦ LIBER ✦

PHP75 Is Orphan Designation a Driver of Orphan Drug Pricing?

✍ Scribed by A. Degrassat-Théas; P. Paubel; O. Parent de Curzon; F. Berard; N. Poisson; C. Le pen; M. Sinègre

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PHP3 PRICING AND REIMBURSEMENT OF ORPHAN

✍ S Lopatriello; C Schivazappa; C Negrini; P Berto 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PHP100 PRICING AND REIMBURSEMENT OF ORPH

✍ J. Kumar; E.M. Bachman 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PHP127 Reimbursement of Orphan Drugs: Wh

✍ E. Mueller; E. Schmidt; J. Ehreth 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PHP15 ASSESSMENT OF ORPHAN DRUGS DEVELOP

✍ E McErlane; P Desai; JJ Guo; W Sietsema; CM Kelton 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PHP46 Market Uptake of Orphan Drugs – A

✍ E. Picavet; D. Cassiman; S. Simoens 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PHP29 ASSESSMENT OF THE ORPHAN DRUG PRIC

✍ Mukku, SR; Pang, F 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB